Pancreatic Cancer Research

ResearcherUniversity of California, IrvineActive in the last 2 years

Nadine Abi‐Jaoudeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6163-8524; OpenAlex author ID A5050356072. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 trial · 2025: none · 2026: 1 paper

Papers 3

  1. Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. Last author DOI 10.1016/j.jvir.2026.108954↗
  2. Irreversible electroporation for pancreatic cancer using intraprocedural cone-beam computed tomography fusion navigation: a case report. Last author DOI 10.1186/s13256-021-03152-2↗
  3. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular i… Co-author DOI 10.1007/s10637-014-0157-7↗

Trials 1

  1. Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma Principal investigator NCT05919238↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer Brooke Goldstein · 1 shared paper, 2026 · strength 0.29
  2. Farshid Dayyani · 1 shared paper, 2026 · strength 0.29
  3. David K. Imagawa · 1 shared paper, 2026 · strength 0.29
  4. Fa-Chyi Lee · 1 shared paper, 2026 · strength 0.29
  5. Ricardo Azevedo · 1 shared paper, 2026 · strength 0.29
  6. Sriram S. Rao · 1 shared paper, 2021 · strength 0.15
  7. Itzhak Avital · 1 shared paper, 2015 · strength 0.05
  8. Joal D. Beane · 1 shared paper, 2015 · strength 0.05
  9. Udo Rudloff · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.